Speakers

Zorica Dragic

Novartis

Unit Head Cell Line Screening and Development

Zorica Dragic Arunasalam leads the Cell Line Development team at Novartis Biologics Center, in Basel responsible for the technical development of all manufacturing cell lines for monoclonal antibodies and therapeutic proteins from early development up to and including the commercial stage.

Zorica graduated in Pharmacy and Medical Biochemistry at the University of Zagreb and obtained her Ph D from the University of Basel, Switzerland. With 12 years of experience in the Pharmaceutical industry, Zorica assumed different roles in the biotechnology area. She led line function teams with core expertise in the cell, process, and technology development, as well as cross-functional CMC teams as technical project lead, looking into technical development and strategic aspects of early pipeline projects In her current role Zorica is leading a team of motivated scientist at the interphase of discovery and development, assuring the success of one of the fastest biologics pipelines in the industry.

More information about this lecture will follow soon

Novartis

Bringing breakthroughs to more patients

Novartis is an innovative medicines company. Every day, they work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Their medicines reach 296 million people worldwide.

Visit the website of Novartis